Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Atara Biotherapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −12 vs. Q2 2024
- Shares held
- 2.41M
- −360.4K (−13.0%) vs. Q2 2024
- Total value
- $19.6M
- −$3.92M (−16.6%) vs. Q2 2024
- New holders
- 4
- 13 more added
- Sold out
- 16
- 11 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $51.3M |
| Q1 2026 | 33 | $12.1M |
| Q4 2025 | 41 | $37.1M |
| Q3 2025 | 37 | $27.0M |
| Q2 2025 | 32 | $13.9M |
| Q1 2025 | 37 | $12.4M |
| Q4 2024 | 43 | $31.5M |
| Q3 2024 | 35 | $19.6M |
| Q2 2024 | 48 | $24.1M |
| Q1 2024 | 82 | $57.8M |
| Q4 2023 | 91 | $33.2M |
| Q3 2023 | 109 | $130.5M |
| Q2 2023 | 118 | $145.8M |
| Q1 2023 | 125 | $297.8M |
| Q4 2022 | 139 | $319.3M |
| Q3 2022 | 155 | $376.2M |
| Q2 2022 | 134 | $777.4M |
| Q1 2022 | 145 | $909.5M |
| Q4 2021 | 139 | $1.50B |
| Q3 2021 | 140 | $1.61B |
| Q2 2021 | 145 | $1.34B |
| Q1 2021 | 151 | $1.24B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Atara Biotherapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 17 | $0 | 0.00% | −2,028−99.2% | Reduced |
| Citigroup Inc | 8 | $65 | 0.00% | −3,164−99.7% | Reduced |
| EverSource Wealth Advisors, LLC | 35 | $285 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 56 | $455 | 0.00% | −36,668−99.8% | Reduced |
| GAMMA Investing LLC | 56 | $455 | 0.00% | +56 | New |
| Catalyst Funds Management Pty Ltd | 100 | $813 | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 129 | $1.00K | 0.00% | −179−58.1% | Reduced |
| Rhumbline Advisers | 175 | $1.42K | 0.00% | −507−74.3% | Reduced |
| IFP Advisors, Inc | 180 | $1.46K | 0.00% | −4,500−96.2% | Reduced |
| Group One Trading, L.P. | 394 | $3.20K | 0.00% | −4,395−91.8% | Reduced |
| UBS Group AG | 402 | $3.27K | 0.00% | −1−0.2% | Reduced |
| Advisor Group Holdings, Inc. | 644 | $5.24K | 0.00% | +644 | New |
| Russell Investments Group, Ltd. | 719 | $5.84K | 0.00% | +717+35,850.0% | Added |
| Global Retirement Partners, LLC | 750 | $6.10K | 0.00% | +750 | New |
| Tower Research Capital LLC (TRC) | 752 | $6.11K | 0.00% | −3,715−83.2% | Reduced |
| Wells Fargo & Company | 1,251 | $10.2K | 0.00% | +936+297.1% | Added |
| JPMorgan Chase & Co | 1,370 | $11.1K | 0.00% | −290−17.5% | Reduced |
| Bridgeway Capital Management, LLC | 14,000 | $113.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 16,189 | $131.6K | 0.00% | +6,404+65.4% | Added |
| State Street Corp | 22,353 | $181.7K | 0.00% | +7,680+52.3% | Added |
| FMR LLC | 25,061 | $203.7K | 0.00% | +7,381+41.7% | Added |
| Staley Capital Advisers Inc | 40,000 | $325.2K | 0.01% | 00.0% | Unchanged |
| Centiva Capital, LP | 43,403 | $352.9K | 0.02% | −96,847−69.1% | Reduced |
| Geode Capital Management, LLC | 46,720 | $379.9K | 0.00% | +4,043+9.5% | Added |
| BlackRock, Inc. | 60,954 | $495.6K | 0.00% | +60,954 | New |
| Renaissance Technologies LLC | 67,734 | $550.7K | 0.00% | +21,670+47.0% | Added |
| Tang Capital Management LLC | 75,196 | $611.3K | 0.04% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 124,677 | $1.01M | 0.08% | +12,677+11.3% | Added |
| Acadian Asset Management LLC | 129,144 | $1.05M | 0.00% | +9,774+8.2% | Added |
| Millennium Management LLC | 176,053 | $1.43M | 0.00% | +59,382+50.9% | Added |
| Vanguard Group Inc | 180,715 | $1.47M | 0.00% | +11,379+6.7% | Added |
| Bank of America Corp | 203,627 | $1.66M | 0.00% | +17,616+9.5% | Added |
| Citadel Advisors LLC | 260,480 | $2.12M | 0.00% | 00.0% | Unchanged |
| Redmile Group, LLC | 452,270 | $3.68M | 0.22% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 468,938 | $3.81M | 0.13% | +62,259+15.3% | Added |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −166,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −102,663−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −70,889−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −36,340−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −31,492−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −26,155−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −15,079−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,455−100.0% | Sold out |
| Lake Street Advisors Group, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −9,271−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −6,292−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −1,927−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −542−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −197−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |